Despite scientific discoveries in the field of gene and cell therapy, some diseases still have
no effective treatment. Advances in genetic engineering methods have enabled the …

There has been a resurgence in gene therapy efforts that is partly fueled by the identification
and understanding of new gene delivery vectors. Adeno-associated virus (AAV) is a non …

The discovery of naturally occurring adeno-associated virus (AAV) isolates in different
animal species and the generation of engineered AAV strains using molecular genetics …

Adeno-associated virus (AAV) forms the basis for several commercial gene therapy products
and for countless gene transfer vectors derived from natural or synthetic viral isolates that …

Emerging coronaviruses (CoV) are constant global public health threats to society. Multiple
ongoing clinical trials for vaccines and antivirals against CoVs showcase the availability of …

The adeno-associated viral vector (AAV) provides a safe and efficient gene therapy platform
with several approved products that have marked therapeutic impact for patients. However …

More than one hundred naturally occurring variants of adeno-associated virus (AAV) have
been identified, and this library has been further expanded by an array of techniques for …

Adeno-associated virus (AAV) vectors are quickly becoming the vectors of choice for
therapeutic gene delivery. To date, hundreds of natural isolates and bioengineered variants …

Vectors based on adeno-associated virus (AAV) serotype 9 are candidates for in vivo gene
delivery to many organs, but the receptor (s) mediating these tropisms have yet to be …

Human bocavirus 1 (HBoV1) has been identified as one of the etiological agents of
wheezing in young children with acute respiratory-tract infections. In this study, we have …